Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy.

Hoh RA, Joshi SA, Lee JY, Martin BA, Varma S, Kwok S, Nielsen SCA, Nejad P, Haraguchi E, Dixit PS, Shutthanandan SV, Roskin KM, Zhang W, Tupa D, Bunning BJ, Manohar M, Tibshirani R, Fernandez-Becker NQ, Kambham N, West RB, Hamilton RG, Tsai M, Galli SJ, Chinthrajah RS, Nadeau KC, Boyd SD.

Sci Immunol. 2020 Mar 6;5(45). pii: eaay4209. doi: 10.1126/sciimmunol.aay4209.

PMID:
32139586
2.

Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signaling.

Folkerts J, Redegeld F, Folkerts G, Blokhuis B, van den Berg MPM, de Bruijn MJW, van IJcken WFJ, Junt T, Tam SY, Galli SJ, Hendriks RW, Stadhouders R, Maurer M.

Allergy. 2020 Feb 28. doi: 10.1111/all.14254. [Epub ahead of print]

PMID:
32112426
3.

Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy.

Folkerts J, Gaudenzio N, Maurer M, Hendriks RW, Stadhouders R, Tam SY, Galli SJ.

Nat Protoc. 2020 Mar;15(3):1285-1310. doi: 10.1038/s41596-019-0288-6. Epub 2020 Feb 14.

PMID:
32060492
4.

The TWEAK/Fn14 axis in anaphylactic shock.

Galli SJ.

J Allergy Clin Immunol. 2020 Feb;145(2):491-493. doi: 10.1016/j.jaci.2019.11.044. No abstract available.

PMID:
32035606
5.

Development of multiple features of antigen-induced asthma pathology in a new strain of mast cell deficient BALB/c-KitW-sh/W-sh mice.

Hernandez JD, Yu M, Sibilano R, Tsai M, Galli SJ.

Lab Invest. 2020 Apr;100(4):516-526. doi: 10.1038/s41374-019-0354-2. Epub 2019 Dec 19.

PMID:
31857699
6.

Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.

Tsai M, Mukai K, Chinthrajah RS, Nadeau KC, Galli SJ.

J Allergy Clin Immunol. 2020 Mar;145(3):885-896.e6. doi: 10.1016/j.jaci.2019.10.038. Epub 2019 Dec 2.

PMID:
31805311
7.

Trends in egg specific immunoglobulin levels during natural tolerance and oral immunotherapy.

Andorf S, Bunning B, Tupa D, Cao S, Long AJ, Borres MP, Galli SJ, Chinthrajah RS, Nadeau KC.

Allergy. 2019 Nov 14. doi: 10.1111/all.14107. [Epub ahead of print] No abstract available.

PMID:
31724180
8.

Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?

Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K, Brough H, Caubet JC, Chan ES, Chen M, Chinthrajah S, Davis CM, Des Roches A, Du Toit G, Elizur A, Galli SJ, Håland G, Hoffmann-Sommergruber K, Kim H, Leung DYM, Long A, Muraro A, Nurmatov UB, Pajno GB, Sampath V, Saxena J, Sindher S, Upton J, Worm M, Nadeau KC.

J Allergy Clin Immunol. 2019 Nov 1. pii: S0091-6749(19)31414-9. doi: 10.1016/j.jaci.2019.10.021. [Epub ahead of print] No abstract available.

PMID:
31678426
9.

MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure.

Keren L, Bosse M, Thompson S, Risom T, Vijayaragavan K, McCaffrey E, Marquez D, Angoshtari R, Greenwald NF, Fienberg H, Wang J, Kambham N, Kirkwood D, Nolan G, Montine TJ, Galli SJ, West R, Bendall SC, Angelo M.

Sci Adv. 2019 Oct 9;5(10):eaax5851. doi: 10.1126/sciadv.aax5851. eCollection 2019 Oct.

10.

Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling.

El Abbas S, Radermecker C, Bai Q, Beguin C, Schyns J, Meunier M, Pirottin D, Desmet CJ, Meuwis MA, Art T, Louis E, Tam SY, Tsai M, Bureau F, Galli SJ, Marichal T.

Mucosal Immunol. 2020 Jan;13(1):96-109. doi: 10.1038/s41385-019-0211-z. Epub 2019 Oct 18.

PMID:
31628426
11.

House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation.

Serhan N, Basso L, Sibilano R, Petitfils C, Meixiong J, Bonnart C, Reber LL, Marichal T, Starkl P, Cenac N, Dong X, Tsai M, Galli SJ, Gaudenzio N.

Nat Immunol. 2019 Nov;20(11):1435-1443. doi: 10.1038/s41590-019-0493-z. Epub 2019 Oct 7.

PMID:
31591569
12.

Mast cells are critical for controlling the bacterial burden and the healing of infected wounds.

Zimmermann C, Troeltzsch D, Giménez-Rivera VA, Galli SJ, Metz M, Maurer M, Siebenhaar F.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20500-20504. doi: 10.1073/pnas.1908816116. Epub 2019 Sep 23.

13.

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.

Chinthrajah RS, Purington N, Andorf S, Long A, O'Laughlin KL, Lyu SC, Manohar M, Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ, Nadeau KC.

Lancet. 2019 Oct 19;394(10207):1437-1449. doi: 10.1016/S0140-6736(19)31793-3. Epub 2019 Sep 12.

PMID:
31522849
14.

ICER report for peanut OIT comes up short.

Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K, Brough H, Caubet JC, Chan ES, Chinthrajah S, Davis CM, Roches AD, Du Toit G, Elizur A, Galli SJ, Håland G, Hoffmann-Sommergruber K, Kim H, Leung DYM, Muraro A, Nurmatov UB, Pajno GB, Sindher S, Szepfalusi Z, Torres MJ, Upton J, Worm M, Nadeau K.

Ann Allergy Asthma Immunol. 2019 Nov;123(5):430-432. doi: 10.1016/j.anai.2019.09.001. Epub 2019 Sep 9. No abstract available.

PMID:
31513908
15.

Future Needs in Mast Cell Biology.

Varricchi G, de Paulis A, Marone G, Galli SJ.

Int J Mol Sci. 2019 Sep 6;20(18). pii: E4397. doi: 10.3390/ijms20184397. Review.

16.

A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.

Andorf S, Purington N, Kumar D, Long A, O'Laughlin KL, Sicherer S, Sampson H, Cianferoni A, Whitehorn TB, Petroni D, Makhija M, Robison RG, Lierl M, Logsdon S, Desai M, Galli SJ, Rael E, Assa'ad A, Chinthrajah S, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Nadeau K.

EClinicalMedicine. 2019 Jan 21;7:27-38. doi: 10.1016/j.eclinm.2018.12.006. eCollection 2019 Jan.

17.

IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis.

Wang Q, Lepus CM, Raghu H, Reber LL, Tsai MM, Wong HH, von Kaeppler E, Lingampalli N, Bloom MS, Hu N, Elliott EE, Oliviero F, Punzi L, Giori NJ, Goodman SB, Chu CR, Sokolove J, Fukuoka Y, Schwartz LB, Galli SJ, Robinson WH.

Elife. 2019 May 14;8. pii: e39905. doi: 10.7554/eLife.39905.

18.

Meningeal Mast Cells as Key Effectors of Stroke Pathology.

Arac A, Grimbaldeston MA, Galli SJ, Bliss TM, Steinberg GK.

Front Cell Neurosci. 2019 Apr 3;13:126. doi: 10.3389/fncel.2019.00126. eCollection 2019.

19.

Recruiting CD33 on mast cells to inhibit IgE-mediated mast cell-dependent anaphylaxis.

Galli SJ.

J Clin Invest. 2019 Mar 1;129(3):955-957. doi: 10.1172/JCI127100. Epub 2019 Feb 18.

20.

Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice.

Piliponsky AM, Shubin NJ, Lahiri AK, Truong P, Clauson M, Niino K, Tsuha AL, Nedospasov SA, Karasuyama H, Reber LL, Tsai M, Mukai K, Galli SJ.

Nat Immunol. 2019 Feb;20(2):129-140. doi: 10.1038/s41590-018-0288-7. Epub 2019 Jan 21.

21.

Complexities in analyzing human basophil responses to autoantibodies to IgE or FcεRI.

Galli SJ.

J Allergy Clin Immunol. 2019 Mar;143(3):932-934. doi: 10.1016/j.jaci.2018.12.998. Epub 2019 Jan 14. No abstract available.

PMID:
30654052
22.

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.

Wright BL, Fernandez-Becker NQ, Kambham N, Purington N, Tupa D, Zhang W, Rank MA, Kita H, Shim KP, Bunning BJ, Doyle AD, Jacobsen EA, Boyd SD, Tsai M, Maecker H, Manohar M, Galli SJ, Nadeau KC, Chinthrajah RS.

Front Immunol. 2018 Nov 22;9:2624. doi: 10.3389/fimmu.2018.02624. eCollection 2018.

23.

Analysis of a Large Standardized Food Challenge Data Set to Determine Predictors of Positive Outcome Across Multiple Allergens.

Sindher S, Long AJ, Purington N, Chollet M, Slatkin S, Andorf S, Tupa D, Kumar D, Woch MA, O'Laughlin KL, Assaad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Galli SJ, Nadeau KC, Chinthrajah RS.

Front Immunol. 2018 Nov 27;9:2689. doi: 10.3389/fimmu.2018.02689. eCollection 2018.

24.

Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges.

Purington N, Chinthrajah RS, Long A, Sindher S, Andorf S, O'Laughlin K, Woch MA, Scheiber A, Assa'ad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Galli SJ, Desai M, Nadeau KC.

Front Immunol. 2018 Sep 21;9:2057. doi: 10.3389/fimmu.2018.02057. eCollection 2018.

25.

Imaging FITC-dextran as a Reporter for Regulated Exocytosis.

Klein O, Roded A, Hirschberg K, Fukuda M, Galli SJ, Sagi-Eisenberg R.

J Vis Exp. 2018 Jun 20;(136). doi: 10.3791/57936.

26.

Mary Hewitt Loveless, MD: The origin of venom immunotherapy.

Galli SJ.

Ann Allergy Asthma Immunol. 2018 Sep;121(3):268-271. doi: 10.1016/j.anai.2018.06.020. Epub 2018 Jun 28. No abstract available.

PMID:
29964225
27.

Genetic and Imaging Approaches Reveal Pro-Inflammatory and Immunoregulatory Roles of Mast Cells in Contact Hypersensitivity.

Gaudenzio N, Marichal T, Galli SJ, Reber LL.

Front Immunol. 2018 Jun 5;9:1275. doi: 10.3389/fimmu.2018.01275. eCollection 2018. Review.

28.

Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases.

Folkerts J, Stadhouders R, Redegeld FA, Tam SY, Hendriks RW, Galli SJ, Maurer M.

Front Immunol. 2018 May 29;9:1067. doi: 10.3389/fimmu.2018.01067. eCollection 2018. Review.

29.

Development of a tool predicting severity of allergic reaction during peanut challenge.

Chinthrajah RS, Purington N, Andorf S, Rosa JS, Mukai K, Hamilton R, Smith BM, Gupta R, Galli SJ, Desai M, Nadeau KC.

Ann Allergy Asthma Immunol. 2018 Jul;121(1):69-76.e2. doi: 10.1016/j.anai.2018.04.020. Epub 2018 Apr 27.

30.

Thirdhand smoke component can exacerbate a mouse asthma model through mast cells.

Yu M, Mukai K, Tsai M, Galli SJ.

J Allergy Clin Immunol. 2018 Nov;142(5):1618-1627.e9. doi: 10.1016/j.jaci.2018.04.001. Epub 2018 Apr 18.

31.

Mast cells as sources of cytokines, chemokines, and growth factors.

Mukai K, Tsai M, Saito H, Galli SJ.

Immunol Rev. 2018 Mar;282(1):121-150. doi: 10.1111/imr.12634. Review.

32.

Food allergy and omics.

Dhondalay GK, Rael E, Acharya S, Zhang W, Sampath V, Galli SJ, Tibshirani R, Boyd SD, Maecker H, Nadeau KC, Andorf S.

J Allergy Clin Immunol. 2018 Jan;141(1):20-29. doi: 10.1016/j.jaci.2017.11.007. Review.

PMID:
29307411
33.

Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE.

Tsai CT, Mukai K, Robinson PV, Gray MA, Waschmann MB, Lyu SC, Tsai M, Chinthrajah RS, Nadeau KC, Bertozzi CR, Galli SJ.

J Allergy Clin Immunol. 2018 May;141(5):1901-1904.e15. doi: 10.1016/j.jaci.2017.11.021. Epub 2017 Dec 14. No abstract available.

34.

Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.

Andorf S, Purington N, Block WM, Long AJ, Tupa D, Brittain E, Rudman Spergel A, Desai M, Galli SJ, Nadeau KC, Chinthrajah RS.

Lancet Gastroenterol Hepatol. 2018 Feb;3(2):85-94. doi: 10.1016/S2468-1253(17)30392-8. Epub 2017 Dec 12.

35.

Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.

Valent P, Akin C, Arock M, Bock C, George TI, Galli SJ, Gotlib J, Haferlach T, Hoermann G, Hermine O, Jäger U, Kenner L, Kreipe H, Majeti R, Metcalfe DD, Orfao A, Reiter A, Sperr WR, Staber PB, Sotlar K, Schiffer C, Superti-Furga G, Horny HP.

EBioMedicine. 2017 Dec;26:17-24. doi: 10.1016/j.ebiom.2017.11.024. Epub 2017 Nov 26. Review.

36.

Rab5 is critical for SNAP23 regulated granule-granule fusion during compound exocytosis.

Klein O, Roded A, Zur N, Azouz NP, Pasternak O, Hirschberg K, Hammel I, Roche PA, Yatsu A, Fukuda M, Galli SJ, Sagi-Eisenberg R.

Sci Rep. 2017 Nov 10;7(1):15315. doi: 10.1038/s41598-017-15047-8.

37.

The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.

Reber LL, Starkl P, Balbino B, Sibilano R, Gaudenzio N, Rogalla S, Sensarn S, Kang D, Raghu H, Sokolove J, Robinson WH, Contag CH, Tsai M, Galli SJ.

PLoS One. 2017 Oct 5;12(10):e0185704. doi: 10.1371/journal.pone.0185704. eCollection 2017.

38.

Immune monitoring for precision medicine in allergy and asthma.

Boyd SD, Hoh RA, Nadeau KC, Galli SJ.

Curr Opin Immunol. 2017 Oct;48:82-91. doi: 10.1016/j.coi.2017.08.007. Epub 2017 Sep 7. Review.

39.

Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Galli SJ, Starkl P, Marichal T, Tsai M.

Trans Am Clin Climatol Assoc. 2017;128:193-221. Review.

40.

The pathophysiology of anaphylaxis.

Reber LL, Hernandez JD, Galli SJ.

J Allergy Clin Immunol. 2017 Aug;140(2):335-348. doi: 10.1016/j.jaci.2017.06.003. Review.

41.

Human mast cells as antigen-presenting cells: When is this role important in vivo?

Galli SJ, Gaudenzio N.

J Allergy Clin Immunol. 2018 Jan;141(1):92-93. doi: 10.1016/j.jaci.2017.05.029. Epub 2017 Jun 15. No abstract available.

PMID:
28624609
42.

A new fluorescent-avidin-based method for quantifying basophil activation in whole blood.

Mukai K, Chinthrajah RS, Nadeau KC, Tsai M, Gaudenzio N, Galli SJ.

J Allergy Clin Immunol. 2017 Oct;140(4):1202-1206.e3. doi: 10.1016/j.jaci.2017.03.052. Epub 2017 Jun 9. No abstract available.

43.

Mast Cells and KIT as Potential Therapeutic Targets in Severe Asthma.

Galli SJ.

N Engl J Med. 2017 May 18;376(20):1983-1984. doi: 10.1056/NEJMe1702653. No abstract available.

PMID:
28514622
44.

Imaging protective mast cells in living mice during severe contact hypersensitivity.

Reber LL, Sibilano R, Starkl P, Roers A, Grimbaldeston MA, Tsai M, Gaudenzio N, Galli SJ.

JCI Insight. 2017 May 4;2(9). pii: 92900. doi: 10.1172/jci.insight.92900. eCollection 2017 May 4.

45.

Reply.

Galli SJ.

J Allergy Clin Immunol. 2017 Jun;139(6):2029-2031. doi: 10.1016/j.jaci.2016.12.988. Epub 2017 Apr 11. No abstract available.

PMID:
28410741
46.

Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide.

Reber LL, Gillis CM, Starkl P, Jönsson F, Sibilano R, Marichal T, Gaudenzio N, Bérard M, Rogalla S, Contag CH, Bruhns P, Galli SJ.

J Exp Med. 2017 May 1;214(5):1249-1258. doi: 10.1084/jem.20161238. Epub 2017 Apr 6.

47.

Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children.

Andorf S, Borres MP, Block W, Tupa D, Bollyky JB, Sampath V, Elizur A, Lidholm J, Jones JE, Galli SJ, Chinthrajah RS, Nadeau KC.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1325-1334.e4. doi: 10.1016/j.jaip.2017.01.016. Epub 2017 Mar 27.

48.

Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.

Ho CCM, Chhabra A, Starkl P, Schnorr PJ, Wilmes S, Moraga I, Kwon HS, Gaudenzio N, Sibilano R, Wehrman TS, Gakovic M, Sockolosky JT, Tiffany MR, Ring AM, Piehler J, Weissman IL, Galli SJ, Shizuru JA, Garcia KC.

Cell. 2017 Mar 9;168(6):1041-1052.e18. doi: 10.1016/j.cell.2017.02.011.

49.

Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.

Mukai K, Karasuyama H, Kabashima K, Kubo M, Galli SJ.

Infect Immun. 2017 Apr 21;85(5). pii: e00053-17. doi: 10.1128/IAI.00053-17. Print 2017 May.

50.

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD.

Cancer Res. 2017 Mar 15;77(6):1261-1270. doi: 10.1158/0008-5472.CAN-16-2234. Epub 2017 Mar 2. Review.

Supplemental Content

Loading ...
Support Center